GRI Bio Inc Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds FUBO Q1 2026 Earnings Narrower Loss Drives Significant EPS Beat MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Higher ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss iQIYI Q1 2026 Earnings EPS Miss Signals Operational Challenges